IT之家 · 智能时代T2·68 pts
- NeuroXess raised 700 million RMB in Series B from investors including SDIC Power, SCGC, and SMIC Capital.
- Funds will support multi-center clinical trials, regulatory approval, and mass production construction for its 'fully implanted, wireless, functional' BCI system.
- R&D focuses on iterating language/vision BCIs and exploring BCI-AI convergence to build real-world physical models.